Images List Premium Download Classic

Hypertension

Hypertension-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Thioredoxin, thioredoxin peptides or derivatives for treatment of age-related hypertension
Board Of Regents, The University Of Texas System
August 09, 2018 - N°20180221454

The incidence of high blood pressure is strikingly high with advancing age, and is an independent prognostic factor for the onset or progression of a variety of cardiovascular disorders (cvd). There is a critical need for a curative therapy against age-related hypertension.
Compositions and methods for treating pulmonary hypertension
Acceleron Pharma Inc.
August 09, 2018 - N°20180221447

In some aspects, the disclosure relates to gdf/bmp antagonists and methods of using gdf/bmp antagonists to treat, prevent, or reduce the progression rate and/or severity of pulmonary hypertension (ph), particularly treating, preventing or reducing the progression rate and/or severity of one or more ph-associated complications. The disclosure also provides methods of using a gdf/bmp antagonist ...
Tyrosine amide derivatives as rho- kinase inhibitors
Chiesi Farmaceutici S.p.a.
August 02, 2018 - N°20180215758

Bicyclic dihydropyrimidine-carboxamide compounds of formula i described herein inhibit rho kinase and may be used for the treatment of many disorders associated with rock enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (copd), idiopathic pulmonary fibrosis (ipf) and pulmonary arterial hypertension (pah).. .
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
5-ht2c receptor agonists and compositions and methods of use
Arena Pharmaceuticals, Inc.
August 02, 2018 - N°20180214455

Provided in some embodiments are compounds of formula a, as defined herein, that modulate the activity of 5-ht2c receptor. Also provided in some embodiments are methods, such as, for weight management, inducing satiety, and decreasing food intake, and for preventing and treating obesity, antipsychotic-induced weight gain, type 2 diabetes, prader-willi syndrome, tobacco/nicotine dependence, drug addiction, alcohol addiction, pathological gambling, ...
The use of kauranes compounds in the manufacture of medicament for treatment of cadiac hypertropy ...
Key-pharma Biomedical Inc.
August 02, 2018 - N°20180214400

The invention relates novel pharmaceutical use of kaurane compounds of formula (i) in treating and preventing cardiac hypertrophy and myocardium remodeling. The said compounds also can significantly ameliorate pulmonary hypertension and preventing vascular hypertrophy.
Devices, systems and methods for creation of a peripherally located fistula
Rox Medical, Inc.
July 26, 2018 - N°20180206845

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula in the limb of the patient. Embodiments include a device for the creation, modification and maintenance of a fistula that includes an integral fistula creation assembly near its distal end that passes through the skin of the patient, through a first vessel such as an artery, and ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Heteroaromatic compounds and their use as dopamine d1 ligands
July 19, 2018 - N°20180200253

And pharmaceutically acceptable salts thereof and n-oxides thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds and the uses of such compounds for the treatment of d1-mediated (or d1-associated) disorders including cognitive and motivational impairments and negative symptoms associated with illnesses such as schizophrenia, depression, bipolar disorder, parkinson's disease, mild ...
Therapeutic regimen for hypertension
Geneticure Llc
July 12, 2018 - N°20180195128

The invention relates to improved methods, devices, and kits for identifying and implementing an appropriate treatment regimen for subjects suffering from hypertension.. .
Potassium-binding agents for treating hypertension and hyperkalemia
Relypsa, Inc.
July 12, 2018 - N°20180193377

The present invention generally relates to methods of treating hypertension (htn) in patients in need thereof wherein the patient optionally further suffers from chronic kidney disease (ckd) or type ii diabetes mellitus (t2dm). The invention also relates to methods of treating hyperkalemia in a patient in need thereof, wherein the patient suffers from ckd, t2dm or htn and ...
Pharmaceutical composition comprising amlodipine and dextromethorphan
Handa Pharmaceuticals, Inc.
July 12, 2018 - N°20180193273

This application provides an oral pharmaceutical composition in a solid form comprising amlodipine or a pharmaceutically acceptable salt thereof, a low dose range of dextromethorphan or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients. The composition is useful for treating hypertension..
5-ht2c receptor agonists and compositions and methods of use
Arena Pharmaceuticals, Inc.
July 05, 2018 - N°20180186797

Provided in some embodiments are compounds herein. Also provided in some embodiments are methods for weight management, inducing satiety, and decreasing food intake, and for preventing and treating obesity, antipsychotic-induced weight gain, type 2 diabetes, prader-willi syndrome, tobacco/nicotine dependence, drug addiction, alcohol addiction, pathological gambling, reward deficiency syndrome, and sex addiction), obsessive-compulsive spectrum disorders and impulse control disorders (including nail-biting ...
G protein-coupled receptor kinase inhibitors and methods for use of the same
The Regents Of The University Of Michigan
July 05, 2018 - N°20180186779

Disclosed herein are novel grk inhibitors and methods for their use in treating or preventing heart disease, such as cardiac failure, cardiac hypertrophy, and hypertension. In particular, disclosed herein are compounds of formula (i) and pharmaceutically acceptable salt thereof, wherein the substituents are as described..
Cardiac health monitoring systems and methods involving hypertension relief device(s) and/or features
Physiocue, Inc.
July 05, 2018 - N°20180185643

Systems and methods involving hypertension monitoring and/or treatment device(s) are disclosed. According to implementations herein, various combination systems, devices and methods that provide therapy and/or monitoring capabilities of a person's blood pressure, incorporating a ppg/ecg integrated sensor within the handle of a hypothermia therapy device for persons with hypertension, are provided..
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of fk506 for the treatment of pulmonary arterial hypertension
The Board Of Trustees Of The Leland Stanford Junior University
July 05, 2018 - N°20180185340

A method for reducing pulmonary hypertension in a mammal that employs fk506 is provided. In certain embodiments, the method comprises administering fk506 to a mammal having pulmonary arterial hypertension associated with defective mbpr2 signaling at a dosage sufficient to reduce blood pressure in the pulmonary artery of the mammal..
Compositions and methods for diagnosis and treatment of inflammation
The United States Of America As Represented By The Secretary Of The Navy
July 05, 2018 - N°20180185316

Compositions including an fatty acid, such as an odd chain fatty acid or a very long even chain fatty acid, and salts and derivatives thereof, and methods for treatment and prophylaxis of conditions related to inflammation and conditions related to inflammation, including anemia of chronic disease, insulin resistance, metabolic syndrome, autoimmune disease, hypertension, diabetes, nonalcoholic fatty liver disease, cardiovascular disease, ...
Methods of treating metabolic syndrome using dopamine receptor agonists
Veroscience, Llc
June 28, 2018 - N°20180177874

The present invention is directed to a method of simultaneously treating hypertension, hypertriglyceridemia, a pro-inflammatory state, a pro-coagulative state, and insulin resistance (with or without treating obesity or endothelial dysfunction), associated with or independent from metabolic syndrome, as well as vascular disease such as cardiovascular, cerebrovascular, or peripheral vascular disease comprising the step of administering to a patient suffering from ...
Intravenous fluid
June 28, 2018 - N°20180177821

Disclosed are intravenous hypertonic electrolyte solutions for treating intracranial hypertension while reducing the risk of inducing hyperchloremic metabolic acidosis. The solutions are characterized by a ratio of sodium-to-chloride (na:cl) ions of 1.2-1.6 and a total osmolarity of 310-400 meq/l for a maintenance solution, and a total osmolarity greater than 1000 meq/l for an initiation solution..
Biomarkers for nanoparticle compositions
Abraxis Bioscience, Llc
June 28, 2018 - N°20180177771

The present invention provides methods and compositions for treating a hyperplasia (such as cancer, restenosis, or pulmonary hypertension) by administering a composition comprising nanoparticles that comprise an mtor inhibitor (such as a limus drug) and an albumin based upon the status of an mtor-activating aberration.. .
Compositions for use in treating pulmonary arterial hypertension
Peloton Therapeutics, Inc.
June 28, 2018 - N°20180177754

The present disclosure provides methods of treating pulmonary arterial hypertension (pah) in a subject in need thereof. Compositions for use in these methods are also provided..
Screening and use of piperidino pyrazolopyrimidine compound
Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences
June 21, 2018 - N°20180172669

Provided is a cell line deposited under the number of cgmcc11091 and preparation method thereof. The method comprises: using a critical downstream gene of the bmp signal, the id1 gene, as a target, then designing dual reporter gene elements to insert in an id1 genome, so as to construct a recombination vector, and transcribing the same in a human embryonic ...
Bicyclic dihydropyrimidine-carboxamide derivatives as rho- kinase inhibitors
Chiesi Farmaceutisi S.p.a.
June 21, 2018 - N°20180170939

Bicyclic dihydropyrimidine-carboxamide compounds of formula i described herein inhibit rho kinase and may be useful in the treatment of many disorders associated with rock enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (copd), idiopathic pulmonary fibrosis (ipf), and pulmonary arterial hypertension (pah).. .
Loading